Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CLBS

Caladrius Biosciences (CLBS)

Caladrius Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLBS
FechaHoraFuenteTítuloSímboloCompañía
09/05/202315:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLBSCaladrius Biosciences Inc
09/05/202315:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
30/03/202315:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLBSCaladrius Biosciences Inc
17/01/202316:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
17/10/202215:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLBSCaladrius Biosciences Inc
14/10/202215:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CLBSCaladrius Biosciences Inc
16/09/202215:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLBSCaladrius Biosciences Inc
15/09/202208:15GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
14/09/202207:00GlobeNewswire Inc.Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
12/09/202207:35GlobeNewswire Inc.Life Sciences Virtual Investor Conference Agenda Announced for September 15thNASDAQ:CLBSCaladrius Biosciences Inc
08/09/202207:00GlobeNewswire Inc.Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022NASDAQ:CLBSCaladrius Biosciences Inc
15/08/202205:57Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLBSCaladrius Biosciences Inc
10/08/202210:40TipRanksAnalysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)NASDAQ:CLBSCaladrius Biosciences Inc
10/08/202207:00GlobeNewswire Inc.Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic CancerNASDAQ:CLBSCaladrius Biosciences Inc
07/08/202207:25TipRanksDawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)NASDAQ:CLBSCaladrius Biosciences Inc
05/08/202205:26TipRanksH.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to RecoverNASDAQ:CLBSCaladrius Biosciences Inc
04/08/202215:05GlobeNewswire Inc.Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CLBSCaladrius Biosciences Inc
02/08/202207:00GlobeNewswire Inc.Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney DiseaseNASDAQ:CLBSCaladrius Biosciences Inc
29/07/202215:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CLBSCaladrius Biosciences Inc
28/07/202207:00GlobeNewswire Inc.Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern TimeNASDAQ:CLBSCaladrius Biosciences Inc
06/07/202207:00GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and HepatologyNASDAQ:CLBSCaladrius Biosciences Inc
09/06/202207:00GlobeNewswire Inc.Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials GroupNASDAQ:CLBSCaladrius Biosciences Inc
08/06/202207:00GlobeNewswire Inc.Caladrius Biosciences to Present at the BIO International Convention 2022NASDAQ:CLBSCaladrius Biosciences Inc
26/05/202207:00GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Poster Presentation at the 2022 American Society of Clinical Oncology Annual MeetingNASDAQ:CLBSCaladrius Biosciences Inc
24/05/202209:15TipRanksCaladrius Biosciences (CLBS) Gets a Buy Rating from Brookline Capital MarketsNASDAQ:CLBSCaladrius Biosciences Inc
24/05/202208:15TipRanksAnalysts Offer Insights on Healthcare Companies: Caladrius Biosciences (CLBS) and Alzamend Neuro (ALZN)NASDAQ:CLBSCaladrius Biosciences Inc
23/05/202215:05GlobeNewswire Inc.Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular DysfunctionNASDAQ:CLBSCaladrius Biosciences Inc
19/05/202207:00GlobeNewswire Inc.Caladrius Biosciences Announces IDMC Recommendation to Advance CLBS201 Trial for the Treatment of Diabetic Kidney DiseaseNASDAQ:CLBSCaladrius Biosciences Inc
18/05/202207:00GlobeNewswire Inc.Caladrius Biosciences to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:CLBSCaladrius Biosciences Inc
09/05/202201:16TipRanksBrookline Capital Markets Thinks Caladrius Biosciences’ Stock is Going to RecoverNASDAQ:CLBSCaladrius Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLBS